NO20025168D0 - DNA som koder for et nytt PROST 03 polypeptid - Google Patents

DNA som koder for et nytt PROST 03 polypeptid

Info

Publication number
NO20025168D0
NO20025168D0 NO20025168A NO20025168A NO20025168D0 NO 20025168 D0 NO20025168 D0 NO 20025168D0 NO 20025168 A NO20025168 A NO 20025168A NO 20025168 A NO20025168 A NO 20025168A NO 20025168 D0 NO20025168 D0 NO 20025168D0
Authority
NO
Norway
Prior art keywords
prost
polypeptide
new
dna encoding
dna
Prior art date
Application number
NO20025168A
Other languages
English (en)
Other versions
NO20025168L (no
Inventor
Ted Lau
Richard J Lin
Deborah Parkes
Gordon Parry
Douglas W Schneider
Renate Steinbrecher
Pamela Toy Van Heuit
John Wu
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20025168D0 publication Critical patent/NO20025168D0/no
Publication of NO20025168L publication Critical patent/NO20025168L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20025168A 2000-04-27 2002-10-28 DNA som koder for et nytt PROST 03 polypeptid NO20025168L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20006500P 2000-04-27 2000-04-27
US09/838,785 US20020009455A1 (en) 2000-04-27 2001-04-20 DNA encoding a novel PROST 03 polypeptide
PCT/US2001/013323 WO2001081577A2 (en) 2000-04-27 2001-04-26 Dna encoding the prost 03 polypeptide

Publications (2)

Publication Number Publication Date
NO20025168D0 true NO20025168D0 (no) 2002-10-28
NO20025168L NO20025168L (no) 2002-12-23

Family

ID=26895434

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025168A NO20025168L (no) 2000-04-27 2002-10-28 DNA som koder for et nytt PROST 03 polypeptid

Country Status (6)

Country Link
US (1) US20020009455A1 (no)
EP (1) EP1278842A2 (no)
JP (1) JP2004504811A (no)
AU (1) AU2001257252A1 (no)
NO (1) NO20025168L (no)
WO (1) WO2001081577A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7202342B1 (en) 1999-11-12 2007-04-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
EP1988097A1 (en) * 2001-05-09 2008-11-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
CA2487907A1 (en) * 2002-06-11 2003-12-18 Glaxosmithkline Biologicals S.A. Immunogenic compositions comprising a xenogenic prostate protein p501s
US20040171554A1 (en) * 2003-02-07 2004-09-02 Genentech, Inc. Compositions and methods for enhancing apoptosis
WO2009045370A2 (en) * 2007-09-28 2009-04-09 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1005546A2 (en) * 1997-02-25 2000-06-07 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
WO1998050567A1 (en) * 1997-05-02 1998-11-12 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
CA2331769A1 (en) * 1998-06-22 1999-12-29 Incyte Pharmaceuticals, Inc. Prostate cancer-associated genes
CA2391369A1 (en) * 1999-11-12 2001-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer

Also Published As

Publication number Publication date
JP2004504811A (ja) 2004-02-19
NO20025168L (no) 2002-12-23
WO2001081577A3 (en) 2002-05-23
AU2001257252A1 (en) 2001-11-07
US20020009455A1 (en) 2002-01-24
WO2001081577A2 (en) 2001-11-01
EP1278842A2 (en) 2003-01-29

Similar Documents

Publication Publication Date Title
ID20068A (id) Mekanisme kerja katup
NO20014282D0 (no) Mikrosvitsjer for nedhulls-anvendelse
DE69905968D1 (de) Eine Fotoresistzusammensetzung
DE60135487D1 (de) Codierer
NO20025168L (no) DNA som koder for et nytt PROST 03 polypeptid
NO971347D0 (no) DNA som koder for humant papillomvirus type 6A
ATE296824T1 (de) Neue pleuromutilinderivate
DE69812311D1 (de) Lauflängenkodierung
NO20021614L (no) DNA som koder for PROST 07-polypeptid
ITTO20010098A0 (it) Struttura a manicotto per blocco cilindri.
NO20021927D0 (no) Positivt indikasjonssystem for sementforskyvning i ringrommet i en brönn
NO20022542D0 (no) DNA som koder for et nytt PROST-Ets-polypeptid
FI20002262A (fi) Menetelmä proteiinin rakenteen muuttamiseksi
FR2759139B1 (fr) Vanne a coulisseau
GB0127017D0 (en) New polypeptide
NO20002575D0 (no) Substituerte oksimer som neurokininantagonister
DE69706326D1 (de) Exzentrische klappe
GB0025572D0 (en) New polypeptide
DE10196520T1 (de) Bewegungsmechanismus
NO20024029D0 (no) Nytt protein og gen som koder for proteinet
DE69716965T2 (de) Ein 2-imidazol-5-on enthaltende, neue fungizide zusammensetzung
KR970064049U (ko) 변압기용 밸브
FR2827267B1 (fr) Tire-bouchon a double point d'appui
GB0012199D0 (en) New polypeptide
FI974550A0 (fi) Styrsystem foer en soekmaskin, som anvaends i samband med ett data- eller telekommunikationsnaet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application